U.S. markets closed
  • S&P 500

    3,629.65
    -5.76 (-0.16%)
     
  • Dow 30

    29,872.47
    -173.77 (-0.58%)
     
  • Nasdaq

    12,094.40
    +57.62 (+0.48%)
     
  • Russell 2000

    1,845.02
    -8.51 (-0.46%)
     
  • Crude Oil

    45.82
    +0.11 (+0.24%)
     
  • Gold

    1,808.20
    +2.70 (+0.15%)
     
  • Silver

    23.43
    +0.07 (+0.29%)
     
  • EUR/USD

    1.1919
    +0.0023 (+0.19%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • GBP/USD

    1.3384
    +0.0025 (+0.19%)
     
  • USD/JPY

    104.4020
    -0.0780 (-0.07%)
     
  • BTC-USD

    18,604.94
    -435.90 (-2.29%)
     
  • CMC Crypto 200

    368.46
    -2.05 (-0.55%)
     
  • FTSE 100

    6,391.09
    -41.08 (-0.64%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Intra-Cellular Therapies' Shares March Higher, Can It Continue?

Zacks Equity Research
·2 min read

As of late, it has definitely been a great time to be an investor in Intra-Cellular Therapies, Inc. ITCI. The stock has moved higher by 28.7% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider ITCI’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as ITCI has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
IntraCellular Therapies Inc. (ITCI) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research